Leigh Charvet Selected Research

Leigh Charvet Research Topics

8	Multiple Sclerosis 04/2022 - 12/2015
2	Fatigue 01/2023 - 12/2018
2	Pruritus (Itching) 05/2022 - 12/2018
2	COVID-19 04/2022 - 07/2020
2	Pain (Aches) 01/2021 - 12/2015
2	Parkinson Disease (Parkinson's Disease) 12/2018 - 11/2018
2	Cognitive Dysfunction 12/2018 - 11/2018
1	Headache (Headaches) 01/2023
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2023
1	Post-Traumatic Headache 01/2023
1	Post-Acute COVID-19 Syndrome 11/2022
1	Infections 04/2022
1	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 01/2022
1	Schizophrenia (Dementia Praecox) 01/2022
1	Mental Disorders (Mental Disorder) 01/2022
1	Substance-Related Disorders (Drug Abuse) 01/2022
1	Depressive Disorder (Melancholia) 01/2022
1	Burns 05/2021
1	Migraine Disorders (Migraine) 01/2021
1	Nervous System Diseases (Neurological Disorders) 12/2018
1	Brain Injuries (Brain Injury) 09/2016

5	salicylhydroxamic acid (SHAM)IBA 01/2023 - 11/2020
2	TESIBA 01/2022 - 07/2020
1	Therapeutic UsesIBA 01/2023
1	Rituximab (Mabthera)FDA Link 04/2022
1	Natalizumab (Tysabri)FDA Link 04/2022
1	Dimethyl FumarateIBA 04/2022
1	Sphingosine-1-Phosphate ReceptorsIBA 04/2022
1	Fingolimod Hydrochloride (FTY720)FDA Link 04/2022
1	diroximel fumarateIBA 04/2022
1	FumaratesIBA 04/2022
1	siponimodIBA 04/2022
1	ocrelizumabIBA 04/2022
1	Indicators and Reagents (Reagents)IBA 01/2021
1	SolutionsIBA 01/2021

14	Transcranial Direct Current Stimulation 01/2023 - 12/2015
4	Cognitive Training 11/2022 - 06/2018
3	Therapeutics 01/2023 - 11/2018
2	Electrodes (Electrode) 05/2022 - 12/2018